Statement of Changes in Beneficial Ownership (4)
January 08 2018 - 4:04PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Mason Michael
|
2. Issuer Name
and
Ticker or Trading Symbol
ALNYLAM PHARMACEUTICALS, INC.
[
ALNY
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
VP, Finance and Treasurer
|
(Last)
(First)
(Middle)
300 THIRD STREET
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
1/4/2018
|
(Street)
CAMBRIDGE, MA 02142
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
1/4/2018
|
|
M
(1)
|
|
1388
|
A
|
$42.22
|
6352
|
D
|
|
Common Stock
|
1/4/2018
|
|
M
(1)
|
|
1667
|
A
|
$63.0
|
8019
|
D
|
|
Common Stock
|
1/4/2018
|
|
M
(1)
|
|
3600
|
A
|
$88.95
|
11619
|
D
|
|
Common Stock
|
1/4/2018
|
|
M
(1)
|
|
2750
|
A
|
$96.45
|
14369
|
D
|
|
Common Stock
|
1/4/2018
|
|
M
(1)
|
|
2750
|
A
|
$96.45
|
17119
|
D
|
|
Common Stock
|
1/4/2018
|
|
M
(1)
|
|
10000
|
A
|
$97.72
|
27119
|
D
|
|
Common Stock
|
1/4/2018
|
|
M
(1)
|
|
6187
|
A
|
$96.45
|
33306
|
D
|
|
Common Stock
|
1/4/2018
|
|
M
(1)
|
|
3439
|
A
|
$63.0
|
36745
|
D
|
|
Common Stock
|
1/4/2018
|
|
S
(1)
|
|
5249
|
D
|
$130.42
(2)
|
31496
|
D
|
|
Common Stock
|
1/4/2018
|
|
S
(1)
|
|
16500
|
D
|
$131.2
(3)
|
14996
|
D
|
|
Common Stock
|
1/4/2018
|
|
S
(1)
|
|
12405
|
D
|
$132.18
(4)
|
2591
|
D
|
|
Common Stock
|
1/4/2018
|
|
S
(1)
|
|
1591
|
D
|
$132.98
(5)
|
1000
|
D
|
|
Common Stock
|
1/4/2018
|
|
S
(1)
|
|
400
|
D
|
$133.83
(6)
|
600
|
D
|
|
Common Stock
|
1/4/2018
|
|
S
(1)
|
|
600
|
D
|
$135.0
(7)
|
0
|
D
|
|
Common Stock
|
|
|
|
|
|
|
|
226
|
I
|
by Managed Account
(8)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Performance Stock Option 2013 (right to buy)
|
$63.0
|
1/4/2018
|
|
M
(1)
|
|
|
1667
|
9/20/2017
|
12/17/2023
|
Common Stock
|
1667
|
$0.0
|
0
|
D
|
|
Performance Stock Option 2014 (right to buy)
|
$96.45
|
1/4/2018
|
|
M
(1)
|
|
|
2750
|
2/1/2016
|
12/17/2024
|
Common Stock
|
2750
|
$0.0
|
2750
|
D
|
|
Performance Stock Option 2014 (right to buy)
|
$96.45
|
1/4/2018
|
|
M
(1)
|
|
|
2750
|
7/7/2017
|
12/17/2024
|
Common Stock
|
2750
|
$0.0
|
0
|
D
|
|
Stock Option (right to buy)
|
$42.22
|
1/4/2018
|
|
M
(1)
|
|
|
1388
|
(9)
|
12/20/2026
|
Common Stock
|
1388
|
$0.0
|
4162
|
D
|
|
Stock Option (right to buy)
|
$63.0
|
1/4/2018
|
|
M
(1)
|
|
|
3439
|
(9)
|
12/18/2023
|
Common Stock
|
3439
|
$0.0
|
0
|
D
|
|
Stock Option (right to buy)
|
$88.95
|
1/4/2018
|
|
M
(1)
|
|
|
3600
|
(9)
|
12/18/2025
|
Common Stock
|
3600
|
$0.0
|
3600
|
D
|
|
Stock Option (right to buy)
|
$96.45
|
1/4/2018
|
|
M
(1)
|
|
|
6187
|
(9)
|
12/17/2024
|
Common Stock
|
6187
|
$0.0
|
2063
|
D
|
|
Stock Option (right to buy)
|
$97.72
|
1/4/2018
|
|
M
(1)
|
|
|
10000
|
12/7/2015
|
12/7/2025
|
Common Stock
|
10000
|
$0.0
|
0
|
D
|
|
Explanation of Responses:
|
(1)
|
All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017.
|
(2)
|
Sale prices ranged from $129.74 to $130.72.
|
(3)
|
Sale prices ranged from $130.74 to $131.73.
|
(4)
|
Sale prices ranged from $131.75 to $132.71.
|
(5)
|
Sale prices ranged from $132.75 to $133.71.
|
(6)
|
Sale prices ranged from $133.78 to $134.11.
|
(7)
|
Sale prices ranged from $134.94 to $135.10
|
(8)
|
The reporting person owns 226 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
|
(9)
|
The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Mason Michael
300 THIRD STREET
CAMBRIDGE, MA 02142
|
|
|
VP, Finance and Treasurer
|
|
Signatures
|
/s/ Michael P. Mason
|
|
1/8/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Oct 2023 to Oct 2024